Examining Access to Primary Care for People With Opioid Use Disorder in Ontario, Canada: A Randomized Clinical Trial

Sheryl Spithoff, Lana Mogic, Susan Hum, Rahim Moineddin, Christopher Meaney, Tara Kiran, Sheryl Spithoff, Lana Mogic, Susan Hum, Rahim Moineddin, Christopher Meaney, Tara Kiran

Abstract

Importance: People with opioid use disorder are less likely than others to have a primary care physician.

Objective: To determine if family physicians are less likely to accept people with opioid use disorder as new patients than people with diabetes.

Design, setting, and participants: This randomized clinical trial used an audit design to survey new patient intake at randomly selected family physicians in Ontario, Canada. Eligible physicians were independent practitioners allowed to prescribe opioids who were located in an office within 50 km of a population center greater than 20 000 people. A patient actor made unannounced telephone calls to family physicians asking for a new patient appointment. The data were analyzed in September 2021.

Intervention: In the first randomly assigned scenario, the patient actor played a role of patient with diabetes in treatment with an endocrinologist. In the second scenario, the patient actor played a role of a patient with opioid use disorder undergoing methadone treatment with an addiction physician.

Main outcomes and measures: Total offers of a new patient appointment; a secondary analysis compared the proportions of patients offered an appointment stratified by gender, population, model of care, and years in practice.

Results: Of a total 383 family physicians included in analysis, a greater proportion offered a new patient appointment to a patient with diabetes (21 of 185 physicians [11.4%]) than with opioid use disorder (8 of 198 physicians [4.0%]) (absolute difference, 7.4%; 95% CI, 2.0 to 12.6; P = .007). Physicians with more than 20 years in practice were almost 13 times less likely to offer an appointment to a patient with opioid use disorder compared with diabetes (1 of 108 physicians [0.9%] vs 10 of 84 physicians [11.9%]; absolute difference, 11.0; 95% CI, 3.8 to 18.1; P = .001). Women were almost 5 times less likely (3 of 111 physicians [2.7%] vs 14 of 114 physicians [12.3%]; absolute difference, 9.6%; 95% CI, 2.4 to 16.3; P = .007) to offer an appointment to a patient with opioid use disorder than with diabetes.

Conclusions and relevance: In this randomized clinical trial, family physicians were less likely to offer a new patient appointment to a patient with opioid use disorder compared with a patient with diabetes. Potential health system solutions to this disparity include strengthening policies for accepting new patients, improved compensation, and clinician anti-oppression training.

Trial registration: ClinicalTrials.gov Identifier: NCT05484609.

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.. Flow Diagram of Trial Participation
Figure.. Flow Diagram of Trial Participation

References

    1. Degenhardt L, Charlson F, Ferrari A, et al. ; GBD 2016 Alcohol and Drug Use Collaborators . The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987-1012. doi:10.1016/S2215-0366(18)30337-7
    1. Anderson KE, Alexander GC, Niles L, Scholle SH, Saloner B, Dy SM. Quality of preventive and chronic illness care for insured adults with opioid use disorder. JAMA Netw Open. 2021;4(4):e214925. doi:10.1001/jamanetworkopen.2021.4925
    1. Wu LT, Zhu H, Ghitza UE. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: results from electronic health records data. Drug Alcohol Depend. 2018;192:316-323. doi:10.1016/j.drugalcdep.2018.08.013
    1. Piske M, Zhou H, Min JE, et al. . The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada. Addiction. 2020;115(8):1482-1493. doi:10.1111/add.14947
    1. Oliva EM, Harris AHS, Trafton JA, Gordon AJ. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors. Drug Alcohol Depend. 2012;122(3):241-246. doi:10.1016/j.drugalcdep.2011.10.004
    1. Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis. J Gen Intern Med. 2020;35(8):2365-2374. doi:10.1007/s11606-020-05815-0
    1. Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005;83(3):457-502. doi:10.1111/j.1468-0009.2005.00409.x
    1. Shi L. The impact of primary care: a focused review. Scientifica (Cairo). 2012;2012:432892. doi:10.6064/2012/432892
    1. Kiran T, Kopp A, Glazier RH. Those left behind from voluntary medical home reforms in Ontario, Canada. Ann Fam Med. 2016;14(6):517-525. doi:10.1370/afm.2000
    1. Kim TW, Samet JH, Cheng DM, Winter MR, Safran DG, Saitz R. Primary care quality and addiction severity: a prospective cohort study. Health Serv Res. 2007;42(2):755-772. doi:10.1111/j.1475-6773.2006.00630.x
    1. Spithoff S, Kiran T, Khuu W, et al. . Quality of primary care among individuals receiving treatment for opioid use disorder. Can Fam Physician. 2019;65(5):343-351.
    1. Haddad MS, Zelenev A, Altice FL. Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers. J Urban Health. 2015;92(1):193-213. doi:10.1007/s11524-014-9924-1
    1. Kendall CE, Boucher LM, Donelle J, et al. . Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Serv Res. 2020;20(1):837. doi:10.1186/s12913-020-05670-z
    1. Benjamin-Johnson R, Moore A, Gilmore J, Watkins K. Access to medical care, use of preventive services, and chronic conditions among adults in substance abuse treatment. Psychiatr Serv. 2009;60(12):1676-1679. doi:10.1176/ps.2009.60.12.1676
    1. Rajaratnam R, Sivesind D, Todman M, Roane D, Seewald R. The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life. J Opioid Manag. 2009;5(1):27-37. doi:10.5055/jom.2009.0004
    1. Gomes T, Campbell TJ, Martins D, et al. . Inequities in access to primary care among opioid recipients in Ontario, Canada: a population-based cohort study. PLoS Med. 2021;18(6):e1003631. doi:10.1371/journal.pmed.1003631
    1. Ross LE, Vigod S, Wishart J, et al. . Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study. BMC Fam Pract. 2015;16:135. doi:10.1186/s12875-015-0353-3
    1. Lavie-Ajayi M, Moran GS, Levav I, et al. . Using the capabilities approach to understand inequality in primary health-care services for people with severe mental illness. Isr J Health Policy Res. 2018;7(1):49. doi:10.1186/s13584-018-0236-x
    1. Melamed OC, Fernando I, Soklaridis S, Hahn MK, LeMessurier KW, Taylor VH. Understanding engagement with a physical health service: a qualitative study of patients with severe mental illness. Can J Psychiatry. 2019;64(12):872-880. doi:10.1177/0706743719862980
    1. Chaar BB, Wang H, Day CA, Hanrahan JR, Winstock AR, Fois R. Factors influencing pharmacy services in opioid substitution treatment. Drug Alcohol Rev. 2013;32(4):426-434. doi:10.1111/dar.12032
    1. Becker WC, Fiellin DA. Provider satisfaction with office-based treatment of opioid dependence: a systematic review. Subst Abus. 2005;26(1):15-22. doi:10.1300/J465v26n01_02
    1. Brar R, Milloy MJ, DeBeck K, et al. . Inability to access primary care clinics among people who inject drugs in a Canadian health care setting. Can Fam Physician. 2021;67(12):e348-e354. doi:10.46747/cfp.6712e348
    1. Crooks VA, Agarwal G, Harrison A. Chronically ill Canadians’ experiences of being unattached to a family doctor: a qualitative study of marginalized patients in British Columbia. BMC Fam Pract. 2012;13:69. doi:10.1186/1471-2296-13-69
    1. Gunner E, Chandan SK, Marwick S, et al. . Provision and accessibility of primary healthcare services for people who are homeless: a qualitative study of patient perspectives in the UK. Br J Gen Pract. 2019;69(685):e526-e536. doi:10.3399/bjgp19X704633
    1. Rosser WW, Colwill JM, Kasperski J, Wilson L. Progress of Ontario’s Family Health Team model: a patient-centered medical home. Ann Fam Med. 2011;9(2):165-171. doi:10.1370/afm.1228
    1. Statistics Canada . Population estimates, quarterly. Revised June 22, 2022. Accessed July 11, 2022.
    1. Martin D, Miller AP, Quesnel-Vallée A, Caron NR, Vissandjée B, Marchildon GP. Canada’s universal health-care system: achieving its potential. Lancet. 2018;391(10131):1718-1735. doi:10.1016/S0140-6736(18)30181-8
    1. Statistics Canada . Primary health care providers, 2019. October 22, 2020. Accessed February 15, 2022.
    1. Kiran T, Kopp A, Moineddin R, Glazier RH. Longitudinal evaluation of physician payment reform and team-based care for chronic disease management and prevention. CMAJ. 2015;187(17):E494-E502. doi:10.1503/cmaj.150579
    1. Olah ME, Gaisano G, Hwang SW. The effect of socioeconomic status on access to primary care: an audit study. CMAJ. 2013;185(6):E263-E269. doi:10.1503/cmaj.121383
    1. College of Physicians and Surgeons of Ontario . Find a Doctor. Accessed January 25, 2019.
    1. Statistics Canada . Population and dwelling counts: Canada and census subdivisions (municipalities) [Internet]. February 9, 2022. Accessed July 11, 2022.
    1. Fahmy N, Kouyoumdjian FG, Berkowitz J, et al. . Access to primary care for persons recently released from prison. Ann Fam Med. 2018;16(6):549-551. doi:10.1370/afm.2314
    1. Marshall EG, Burge F, Gibson RJ, Lawson B, O’Connell C. Accepting new patients who require opioids into family practice: results from the MAAP-NS census survey study. BMC Fam Pract. 2019;20(1):141. doi:10.1186/s12875-019-1027-3
    1. Lagisetty PA, Healy N, Garpestad C, Jannausch M, Tipirneni R, Bohnert ASB. Access to primary care clinics for patients with chronic pain receiving opioids. JAMA Netw Open. 2019;2(7):e196928. doi:10.1001/jamanetworkopen.2019.6928
    1. Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the “narc” cabinet. J Gen Intern Med. 2002;17(5):327-333. doi:10.1007/s11606-002-0034-5
    1. Wenghofer EF, Wilson L, Kahan M, et al. . Survey of Ontario primary care physicians’ experiences with opioid prescribing. Can Fam Physician. 2011;57(3):324-332.
    1. Anstice S, Strike CJ, Brands B. Supervised methadone consumption: client issues and stigma. Subst Use Misuse. 2009;44(6):794-808. doi:10.1080/10826080802483936
    1. Earnshaw V, Smith L, Copenhaver M. Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addict. 2013;11(1):110-122. doi:10.1007/s11469-012-9402-5
    1. Urbanoski K, Pauly B, Inglis D, et al. . Defining culturally safe primary care for people who use substances: a participatory concept mapping study. BMC Health Serv Res. 2020;20(1):1060. doi:10.1186/s12913-020-05915-x
    1. Rao H, Mahadevappa H, Pillay P, Sessay M, Abraham A, Luty J. A study of stigmatized attitudes towards people with mental health problems among health professionals. J Psychiatr Ment Health Nurs. 2009;16(3):279-284. doi:10.1111/j.1365-2850.2008.01369.x
    1. Kennedy-Hendricks A, Busch SH, McGinty EE, et al. . Primary care physicians’ perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 2016;165(165):61-70. doi:10.1016/j.drugalcdep.2016.05.010
    1. FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18(1):19. doi:10.1186/s12910-017-0179-8
    1. Thavam T, Devlin RA, Thind A, Zaric GS, Sarma S. The impact of the diabetes management incentive on diabetes-related services: evidence from Ontario, Canada. Eur J Health Econ. 2020;21(9):1279-1293. doi:10.1007/s10198-020-01216-6
    1. Guan Q, Khuu W, Spithoff S, et al. . Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014. Drug Alcohol Depend. 2017;177:315-321. doi:10.1016/j.drugalcdep.2017.05.002
    1. Osborne G. The last United States election represents a paradigm shift in drug policy, says U of A Augustana professor. University of Alberta news release. March 12, 2021. Accessed October 22, 2021.
    1. Scottish Government . Public attitudes towards people with drug dependence and people in recovery—Research Findings. June 10, 2016. Accessed October 22, 2021.
    1. Gorfinkel L, Klimas J, Reel B, et al. . In-hospital training in addiction medicine: a mixed-methods study of health care provider benefits and differences. Subst Abus. 2019;40(2):207-213. doi:10.1080/08897077.2018.1561596
    1. Klimas J, Ahamad K, Fairgrieve C, et al. . Impact of a brief addiction medicine training experience on knowledge self-assessment among medical learners. Subst Abus. 2017;38(2):141-144. doi:10.1080/08897077.2017.1296055
    1. Blake H, Leighton P, van der Walt G, Ravenscroft A. Prescribing opioid analgesics for chronic non-malignant pain in general practice—a survey of attitudes and practice. Br J Pain. 2015;9(4):225-232. doi:10.1177/2049463715579284
    1. McColl MA, Aiken A, Schaub M. Do people with disabilities have difficulty finding a family physician? Int J Environ Res Public Health. 2015;12(5):4638-4651. doi:10.3390/ijerph120504638
    1. Franklin GM, Fulton-Kehoe D, Turner JA, Sullivan MD, Wickizer TM. Changes in opioid prescribing for chronic pain in Washington State. J Am Board Fam Med. 2013;26(4):394-400. doi:10.3122/jabfm.2013.04.120274
    1. Price D, Baker E. Patient Care Groups: A new model of population based primary health care for Ontario. Primary Health Care Expert Advisory Committee. Published May 2015. Accessed March 18, 2022.
    1. College of Physicians and Surgeons on Ontario . Policy # 1-17 Accepting New Patients. Updated May 2017. Accessed January 28, 2019.
    1. Smith V, Marshall EG. “Meet and greets” in family practice: who, why, and to what end? Can Fam Physician. 2021;67(8):e227-e234. doi:10.46747/cfp.6708e227
    1. Bayoumi I, Schultz SE, Glazier RH. Primary care reform and funding equity for mental health disorders in Ontario: a retrospective observational population-based study. CMAJ Open. 2020;8(2):E455-E461. doi:10.9778/cmajo.20190153
    1. Chapman EN, Kaatz A, Carnes M. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. J Gen Intern Med. 2013;28(11):1504-1510. doi:10.1007/s11606-013-2441-1
    1. Alves PCG, Stevenson FA, Mylan S, Pires N, Winstock A, Ford C. How do people who use drugs experience treatment? a qualitative analysis of views about opioid substitution treatment in primary care (iCARE study). BMJ Open. 2021;11(2):e042865. doi:10.1136/bmjopen-2020-042865
    1. Kiran T, Wang R, Handford C, et al. . Keeping doors open: A cross-sectional survey of family physician practice patterns during COVID-19, needs, and intentions. medRxiv. Preprint posted December 21, 2021. doi:10.1101/2021.12.20.21267918
    1. Kiran T, Green ME, Wu FC, et al. . Did the COVID-19 pandemic result in more family physicians stopping practice? Results from Ontario, Canada. medRxiv. Preprint posted September 22, 2021. doi:10.1101/2021.09.21.21263891

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir